Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Enterprise Value: 2010-2019

Historic Enterprise Value for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to $167.6 million.

  • EyePoint Pharmaceuticals' Enterprise Value rose 25.05% to $167.6 million in Q4 2019 from the same period last year, while for Dec 2019 it was $167.6 million, marking a year-over-year increase of 624.51%. This contributed to the annual value of $508.5 million for FY2024, which is 37.69% down from last year.
  • According to the latest figures from Q4 2019, EyePoint Pharmaceuticals' Enterprise Value is $167.6 million, which was up 31.60% from $127.3 million recorded in Q1 2019.
  • EyePoint Pharmaceuticals' 5-year Enterprise Value high stood at $210.2 million for Q3 2018, and its period low was $35.4 million during Q3 2017.
  • Its 3-year average for Enterprise Value is $91.7 million, with a median of $61.9 million in 2017.
  • In the last 5 years, EyePoint Pharmaceuticals' Enterprise Value slumped by 66.11% in 2016 and then soared by 493.67% in 2018.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Enterprise Value stood at $120.7 million in 2015, then slumped by 66.11% to $40.9 million in 2016, then fell by 12.00% to $36.0 million in 2017, then spiked by 272.25% to $134.0 million in 2018, then grew by 25.05% to $167.6 million in 2019.
  • Its last three reported values are $167.6 million in Q4 2019, $127.3 million for Q1 2019, and $134.0 million during Q4 2018.